ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

How the Treatment Paradigm for EGFR+ Lung Cancer Will Transform

Justin F. Gainor, MD
Published Online:4:17 PM, Mon November 27, 2017

Justin F. Gainor, MD, medical oncologist, Assistant Professor of Medicine, Massachusetts General Hospital, Harvard Medical School, discusses how the treatment paradigm for EGFR+ lung cancer will transform over the next several years.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.